Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 1/20 | 0.31 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.31 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19143464 | 0.88 | LGALS8 (0.32) | — | |
| SCHEMBL14037462 | 0.88 | LGALS8 (0.32) | — | |
| SCHEMBL14537125 | 0.84 | SSTR5 (0.39) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL14624332 | 0.81 | SSTR5 (0.39) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL1642428 | 0.80 | ITPR3 (0.30) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL16248353 | 0.80 | SSTR1 (0.30) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19608814 | 0.80 | ITPR3 (0.30) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL10005839 | 0.80 | ITPR3 (0.30) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19577793 | 0.80 | SSTR1 (0.30) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL17754494 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11033571-B2 | Pharmaceutical composition for preventing or treating hepatitis B | AM SCIENCES INC (KR) | 2021-06-15 | — | — | US | disclosed |
| US-20190343864-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS B | AM SCIENCES INC (KR) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190343864-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS B | DDX21, HAVCR2, DHX36 | SSTR1 4819/4885SSTR2 4818/4885SSTR4 4626/4885 |
| US-11033571-B2 | Pharmaceutical composition for preventing or treating hepatitis B | DDX21, HAVCR2, DHX36 | SSTR1 4819/4885SSTR2 4818/4885SSTR4 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.